In ORBIT-3 the median time to first PE was 214 days in the Linhaliq treatment group as compared to 136 days in the placebo group. This increase of 78 days in the median time to first PE was similar to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback